SCHEMBL15619200

SCHEMBL15619200

COc1ccc(Br)cc1C=CC(=O)c1c(O)cccc1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 4/20 0.72
▸ AR P10275 2/20 0.61
▸ TNFRSF1A P19438 2/20 0.60
▸ AURKA O14965 1/20 0.60
▸ NPSR1 Q6W5P4 2/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ MAPT P10636 3/20 0.55
▸ LMNA P02545 2/20 0.55
▸ HTT P42858 2/20 0.55
▸ ATM Q13315 2/20 0.55
▸ MEN1 O00255 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ MITF O75030 1/20 0.55
▸ PAX8 Q06710 1/20 0.55
▸ HPGD P15428 1/20 0.54
▸ MAOA P21397 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15619199 1.00 MAOB (0.72) MAOBARTNFRSF1AAURKANPSR1
SCHEMBL16948578 0.88 MAOB (0.60) MAOBARTNFRSF1AAURKANPSR1
SCHEMBL16928591 0.87 MAOB (0.62) MAOBARTNFRSF1AAURKANPSR1
SCHEMBL16928594 0.87 MAOB (0.62) MAOBARTNFRSF1AAURKANPSR1
SCHEMBL5084246 0.86 AURKA (0.69) MAOBTNFRSF1AAURKACYP3A4MAPT
SCHEMBL5084241 0.86 AURKA (0.69) MAOBTNFRSF1AAURKACYP3A4MAPT
SCHEMBL19183469 0.84 AURKA (0.66) MAOBARAURKACYP3A4MAOA
SCHEMBL19183470 0.84 AURKA (0.66) MAOBARAURKACYP3A4MAOA
SCHEMBL19183188 0.84 MAOB (0.72) MAOBARAURKANPSR1MAPT
SCHEMBL19183190 0.84 MAOB (0.72) MAOBARAURKANPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9629822-B2 Flavonoid based antiviral targets UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2017-04-25 — — US disclosed
US-20150209323-A1 FLAVONOID BASED ANTIVIRAL TARGETS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, (US) 2015-07-30 — — US disclosed
WO-2014047551-A1 FLAVONOID BASED ANTIVIRAL TARGETS UNIVERSITY OF CENTER FLORIDA RESEARCH FOUNDATION, INC. (US) 2014-03-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150209323-A1 FLAVONOID BASED ANTIVIRAL TARGETS RBM28, MAVS, HAVCR2 MAOB 4153/4885AR 4201/4885TNFRSF1A 357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback